Hanne Leth Hillman

Vorsitzender bei The Danish Investor Relations Society

59 Jahre

Health Technology

Transportation

Finance

Aktive Positionen von Hanne Leth Hillman

Unternehmen	Position	Beginn	Ende
The Danish Investor Relations Society	Vorsitzender	-	-
The Danish Investor Relations Society	Direktor/Vorstandsmitglied	-	-
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Finanzdirektor/CFO	01.05.2017	-

Unternehmen	Position	Beginn	Ende
BRAIN+ A/S	Direktor/Vorstandsmitglied	01.05.2021	01.01.2024
	Finanzdirektor/CFO	01.09.2022	01.01.2024
	Independent Dir/Board Member	01.05.2021	01.09.2022
ZEALAND PHARMA A/S	Investor Relations Kontakt	01.01.2011	01.10.2016
ZEALAND PHARMA A/S	Public Communications Contact	01.01.2011	01.10.2016
Gudme Raaschou Bank A/S	Analyst-Equity	05.11.2004	05.11.2004
NTG NORDIC TRANSPORT GROUP A/S	Investor Relations Kontakt	-	-
NTG NORDIC TRANSPORT GROUP A/S	Public Communications Contact	28.08.2009	-

University of Aarhus

Masters Business Admin

International

Dänemark

Operativ

Investor Relations Contact	2
Public Communications Contact	2
Director/Board Member	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
NTG NORDIC TRANSPORT GROUP A/S	Transportation
ZEALAND PHARMA A/S	Health Technology
BRAIN+ A/S	Technology Services

Private Unternehmen	3
Gudme Raaschou Bank A/S	Finance
The Danish Investor Relations Society
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Health Technology